60 Stocks Moving In Monday's Mid-Day Session

Loading...
Loading...

Gainers

  • Morphic Holding, Inc. MORF shares jumped 109.9% to $75.89 after the company reported FY20 sales of $45 million, up from $17 million year over year. The company also reported "positive" interim results from single ascending dose Phase 1 clinical trial of MORF-057.
  • electroCore, Inc. ECOR shares climbed 53.4% to $3.3284 after the company announced an Exclusive Distribution Agreement with Medistar following regulatory approval in Australia.
  • SOS Limited SOS climbed 46.6% to $6.99. SOS shares dropped 21% on Friday after Hindenberg Research issued a short report on the stock and set a $0 price target.
  • Aemetis, Inc. AMTX gained 46.5% to $14.40 after the company disclosed five-year plan targeting $1 billion of revenue by 2025.
  • Canaan Inc. CAN rose 37% to $20.75.
  • The9 Limited NCTY rose 36.8% to $44.71 after dropping over 20% on Friday. The9 recently acquired 70% equity in Hangzhou SuanLi Technology Co. Ltd. (Interhash), a cryptocurrency cloud mining blockchain software-as-a-service company for approximately $7 million.
  • Vector Acquisition Corporation VACQ shares jumped 30% to $13.32. Rocket Lab USA Inc. will go public through a merger with Vector Acquisition in a $4.1 billion deal.
  • HCI Group, Inc. HCI gained 29.3% to $74.83 after the company late Friday announced Centerbridge Partners invested $100 million in its TypTap subsidiary.
  • Iteris, Inc. ITI climbed 27% to $7.00 after the company announced the Board of Directors unanimously rejected an unsolicited proposal from Rekor Systems.
  • ZK International Group Co., Ltd. ZKIN rose 26.4% to $7.60.
  • Viomi Technology Co., Ltd VIOT surged 24.7% to $12.94.
  • Boingo Wireless, Inc. WIFI jumped 23.7% to $14.10 following news the company will be acquired by Digital Colony for $14 per share in cash.
  • Groupon, Inc. GRPN surged 23.2% to $53.46. JP Morgan upgraded Groupon from Underweight to Neutral and announced a $48 price target. Groupon, last week, reported better-than-expected Q4 EPS and sales results.
  • PLx Pharma Inc. PLXP gained 22.5% to $9.10 after the company announced it received FDA Approval on its SNDAs for both its VAZALORE 325 mg and 81 mg.
  • Apollo Endosurgery, Inc. APEN shares gained 20.4% to $5.64 after the company said it received FDA breakthrough device designation for the orbera intragastric balloon for treatment of patients with NASH.
  • The ExOne Company XONE gained 20.3% to $41.04.
  • Rayonier Advanced Materials Inc. RYAM jumped 20.1% to $11.11. Rayonier Advanced, last week, reported upbeat quarterly results.
  • Marathon Digital Holdings, Inc. MARA gained 19.7% to $36.12 amid continued momentum in Bitcoin.
  • ASLAN Pharmaceuticals Limited ASLN rose 19.6% to $5.30 after the company reported positive interim unblinded data from its ongoing Phase 1 study evaluating ASLAN004 to treat moderate to severe atopic dermatitis.
  • CleanSpark, Inc. CLSK gained 19.6% to $28.61.
  • One Stop Systems, Inc. OSS surged 19.4% to $7.70.
  • Ideanomics, Inc. IDEX gained 19% to $3.795.
  • Professional Diversity Network, Inc. IPDN gained 18.4% to $3.2789.
  • Novan, Inc. NOVN rose 18.3% to $1.68 after dropping 11% on Friday. The company last week reported FY 2020 loss of $0.30 per share.
  • Kopin Corporation KOPN gained 18% to $9.86. Kopin is expected to report its next round of earnings this Tuesday, March 02.
  • Cullinan Oncology, Inc. CGEM surged 17.9% to $47.67.
  • Cars.com Inc. CARS surged 17.4% to $13.70. Cars.com, last week, released Q4 results.
  • R. R. Donnelley & Sons Company RRD gained 16.5% to $3.96.
  • Brickell Biotech, Inc. BBI shares rose 16.4% to $1.3850. Brickell Biotech is expected to release quarterly results on March 9.
  • Riot Blockchain, Inc. RIOT rose 16.1% to $2.37.
  • NRG Energy, Inc. NRG surged 16.1% to $42.40 after the company reaffirmed 2021 EBITDA guidance.
  • Kubient, Inc. KBNT rose 15.8% to $8.00 after dropping 13% on Friday.
  • Holicity Inc. HOL shares rose 14.7% to $16.00 following tweet from Astra highlighting partnership with NASA.
  • Pyxis Tankers Inc. PXS rose 14.4% to $1.43. Pyxis Tankers, last week, announced closing of $25.0 million private placement of common stock.
  • Zomedica Corp. ZOM rose 14.4% to $2.14 after the company reported a narrower FY20 loss.
  • Kirkland's, Inc. KIRK gained 13.6% to $29.55.
  • Luokung Technology Corp. LKCO rose 13.6% to $1.7611 after dropping over 14% on Friday. Luokung Technology last month announced a roughly 48 million share common stock offering priced at $2.08 per share.
  • WiMi Hologram Cloud Inc. WIMI rose 13.3% to $9.39 after the company disclosed a strategic cooperation with the Dream Classroom program of China Education Television.
  • Socket Mobile, Inc. SCKT rose 12.1% to $11.78. Socket Mobile and SpringCard SAS reported a licensing agreement to enable improved contactless customer experiences.
  • Qutoutiao Inc. QTT rose 11.5% to $3.89. Qutoutia is expected to report Q4 earnings on March 4.
  • Urban Tea, Inc. MYT rose 11% to $4.8586 after dropping 13% on Friday. Urban Tea, last month, appointed new COO and independent director to drive expansion in blockchain and cryptocurrency mining business.
  • BriaCell Therapeutics Corp. BCTX rose 10.8% to $3.71. BriaCell reported closing of $25 million public offering.
  • AMC Entertainment Holdings, Inc. AMC rose 10.4% to $8.85. AMC Entertainment’s CEO and President Adam Aron, among other top executives, received big bonuses, according to an SEC filing Friday by the world’s largest movie theater chain.
  • Salarius Pharmaceuticals, Inc. SLRX rose 9.4% to $1.97. Salarius Pharmaceuticals recently announced plans to expand its phase 1/2 clinical trial of Seclidemstat in patients with Ewing Sarcoma and Ewing-Related Sarcomas.
  • XpresSpa Group, Inc. XSPA rose 8.4% to $1.9081. XpresSpa Group and United Airlines, last week, announced the opening of a second XpresCheck COVID-19 testing facility at Newark Liberty International Airport.
  • Astrotech Corporation ASTC rose 8.2% to $2.37 after declining 7% on Friday.
  • NavSight Holdings, Inc. NSH rose 7.7% to $11.27. Spire Global will go public through a merger with NavSight Holdings in a $1.6 billion deal.
  • ChromaDex Corporation CDXC rose 6.7% to $14.86 after dipping over 25% on Friday. ChromaDex, last month, entered into a securities purchase agreement to sell $25 million in common stock via a private placement led by a new international investor.

 

Check out these big penny stock gainers and losers

Losers

  • Athenex, Inc. ATNX shares dipped 50.9% to $5.94 after the company's marketing application for oral paclitaxel to treat metastatic breast cancer was denied by the FDA.
  • Ontrak, Inc. OTRK fell 48.5% to $30.34 after the company issued FY21 sales guidance below analyst estimates.
  • CorMedix Inc. CRMD fell 39.6% to $9.06 after the FDA has issued a Complete Response Letter for CorMedix’s marketing application seeking approval for DefenCath (taurolidine/heparin catheter lock solution) for catheter-related bloodstream infections. FDA noted concerns at the third-party manufacturing facility after reviewing records, though the agency did not specify the issues.
  • Nabriva Therapeutics plc NBRV dipped 18% to $1.96 after the company announced a $25.4 million registered direct offering priced at-the-market under NASDAQ rules.
  • Lixte Biotechnology Holdings, Inc. LIXT fell 16% to $4.6925 after jumping 48% on Friday. Lixte holdings is a drug discovery company focused on creating drugs that will help patients with cancer. Lixte’s main product in the pipeline is, per the company’s website, “a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100.”
  • CLPS Incorporation CLPS dipped 15.3% to $4.97 after the company priced 2,666,666 share registered direct offering at $6 per share.
  • Guardion Health Sciences, Inc. GHSI fell 13.4% to $2.6222 following 1:6 reverse stock split.
  • BioVie Inc. BIVI fell 13.1% to $27.90.
  • Chindata Group Holdings Limited CD shares dropped 11.3% to $20.97. Chindata is expected to report Q4 earnings on March 24.
  • Civeo Corporation CVEO fell 9.2% to $17.06.
  • Denali Therapeutics Inc. DNLI dropped 6.8% to $66.90. Denali Therapeutics, last week, reported a Q4 profit.
  • Zealand Pharma A/S ZEAL fell 6.1% to $33.00 after gaining more than 10% on Friday.
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasHealth CareIndustrial MachineryIndustrialsMid-Day MoversPharmaceuticalsTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...